These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25751397)

  • 1. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments.
    Quteineh L; Vandenberghe F; Saigi Morgui N; Delacrétaz A; Choong E; Gholam-Rezaee M; Magistretti P; Bondolfi G; Von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Bochud M; Kutalik Z; Conus P; Eap CB
    Pharmacogenet Genomics; 2015 May; 25(5):246-58. PubMed ID: 25751397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in Bosnian population.
    Dujic T; Bego T; Mlinar B; Semiz S; Malenica M; Prnjavorac B; Ostanek B; Marc J; Causevic A
    Biochem Med (Zagreb); 2012; 22(1):76-85. PubMed ID: 22384521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HSD11B1 gene polymorphisms with type 2 diabetes and metabolic syndrome in South Indian population.
    Devang N; Satyamoorthy K; Rai PS; Nandini M; Rao S; Phani NM; Adhikari P
    Diabetes Res Clin Pract; 2017 Sep; 131():142-148. PubMed ID: 28750217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gene variant of 11β-hydroxysteroid dehydrogenase type 1 is associated with obesity in children.
    Olza J; Gil-Campos M; Leis R; Rupérez AI; Tojo R; Cañete R; Gil A; Aguilera CM
    Int J Obes (Lond); 2012 Dec; 36(12):1558-63. PubMed ID: 22310475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments.
    Saigi-Morgui N; Vandenberghe F; Delacrétaz A; Quteineh L; Choong E; Gholamrezaee M; Magistretti P; Aubry JM; von Gunten A; Preisig M; Castelao E; Vollenweider P; Waeber G; Kutalik Z; Conus P; Eap CB
    J Clin Psychopharmacol; 2015 Oct; 35(5):544-52. PubMed ID: 26280835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between a 11β-hydroxysteroid dehydrogenase type 1 gene polymorphism and metabolic syndrome in a South Indian population.
    Gandhi K; Adhikari P; Basu A; Achappa B
    Metab Syndr Relat Disord; 2013 Dec; 11(6):397-402. PubMed ID: 23869418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.
    Delacrétaz A; Zdralovic A; Vandenberghe F; Saigi-Morgui N; Glatard A; Quteineh L; Gholam-Rezaee M; Raffoul W; Applegate LA; Jafari P; Gamma F; von Gunten A; Conus P; Eap CB
    Gene; 2017 Sep; 628():8-15. PubMed ID: 28694205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
    Draper N; Echwald SM; Lavery GG; Walker EA; Fraser R; Davies E; Sørensen TI; Astrup A; Adamski J; Hewison M; Connell JM; Pedersen O; Stewart PM
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4984-90. PubMed ID: 12414862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.
    Gambineri A; Tomassoni F; Munarini A; Stimson RH; Mioni R; Pagotto U; Chapman KE; Andrew R; Mantovani V; Pasquali R; Walker BR
    Eur J Endocrinol; 2011 Aug; 165(2):283-92. PubMed ID: 21622477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of 11beta-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort.
    Miyamoto Y; Morisaki H; Yamanaka I; Kokubo Y; Masuzaki H; Okayama A; Tomoike H; Nakao K; Okamura T; Yoshimasa Y; Morisaki T
    Diabetes Res Clin Pract; 2009 Aug; 85(2):132-8. PubMed ID: 19535162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
    Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
    Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
    Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome.
    Robitaille J; Brouillette C; Houde A; Després JP; Tchernof A; Vohl MC
    Obes Res; 2004 Oct; 12(10):1570-5. PubMed ID: 15536220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 11β HSD 1, rs12086634, and rs846910 single-nucleotide polymorphisms in metabolic-related skin diseases: a clinical, biochemical, and genetic study.
    Farag AGA; Badr EA; Eltorgoman AMA; Assar MF; Elshafey EN; Tayel NR; Aboutaleb HE
    Clin Cosmet Investig Dermatol; 2019; 12():91-102. PubMed ID: 30774405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Variation in the 11β-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity.
    Lutz SZ; Peter A; Machicao F; Lamprinou A; Machann J; Schick F; Königsrainer I; Königsrainer A; Fritsche A; Staiger H; Häring HU; Stefan N; Kantartzis K
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4743-4751. PubMed ID: 27715400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Selected Polymorphisms rs12086634, rs846910, rs4844880, rs3753519 of 11β-Hydroxysteroid Dehydrogenase Type 1 (
    Szweda-Gandor N; Śnit M; Grzeszczak W
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
    Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population.
    Choong E; Quteineh L; Cardinaux JR; Gholam-Rezaee M; Vandenberghe F; Dobrinas M; Bondolfi G; Etter M; Holzer L; Magistretti P; von Gunten A; Preisig M; Vollenweider P; Beckmann JS; Pralong FP; Waeber G; Kutalik Z; Conus P; Bochud M; Eap CB;
    JAMA Psychiatry; 2013 Oct; 70(10):1011-9. PubMed ID: 23925723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic risk scores with body mass index in Swiss psychiatric cohorts.
    Saigi-Morgui N; Vandenberghe F; Delacrétaz A; Quteineh L; Gholamrezaee M; Aubry JM; von Gunten A; Kutalik Z; Conus P; Eap CB
    Pharmacogenet Genomics; 2016 May; 26(5):208-17. PubMed ID: 26918956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.